Michel Longy Selected Research

Michel Longy Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 11/2012
8	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2005
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 06/2011
2	Hamartoma 01/2020 - 01/2013
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 12/2012
2	Neoplasm Metastasis (Metastasis) 02/2014 - 06/2011
2	Genomic Instability 02/2014 - 11/2012
2	Multiple Hamartoma Syndrome (Cowden's Disease) 01/2013 - 05/2004
2	Leiomyosarcoma 12/2012 - 10/2006
2	Melanoma (Melanoma, Malignant) 10/2011 - 07/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Adrenocortical Carcinoma 01/2018
1	Carcinoma (Carcinomatosis) 02/2014
1	Adenoma (Adenomas) 02/2014
1	Proteus Syndrome 01/2013
1	Thymoma (Thymic Carcinoma) 12/2012
1	Hemangiosarcoma (Angiosarcoma) 12/2012
1	Aneuploidy (Aneuploid) 11/2012
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 11/2012
1	Chromosome Breakage 11/2012
1	Hypoxia (Hypoxemia) 10/2011
1	Carcinogenesis 10/2011
1	Kidney Neoplasms (Kidney Cancer) 10/2011
1	Endometrial Neoplasms (Endometrial Cancer) 06/2011
1	Cutaneous Malignant Melanoma 07/2008
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 08/2007
1	Dermatofibrosarcoma 10/2006
1	Myxoid Liposarcoma 10/2006
1	Xeroderma Pigmentosum (Kaposi's Disease) 10/2006
1	Synovial Sarcoma (Synovioma) 10/2006
1	Malignant Fibrous Histiocytoma 10/2006
1	Cockayne Syndrome (Syndrome, Cockayne) 10/2006
1	Colorectal Neoplasms (Colorectal Cancer) 12/2004

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2005
5	Proteins (Proteins, Gene)FDA Link 05/2014 - 11/2005
3	TensinsIBA 01/2013 - 05/2004
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2013 - 05/2004
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2021
1	Messenger RNA (mRNA)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Imatinib Mesylate (Gleevec)FDA Link 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2018
1	Calcibiotic Root Canal SealerIBA 02/2014
1	Estrogen ReceptorsIBA 07/2013
1	human ERBB2 proteinIBA 07/2013
1	Hormones (Hormone)IBA 07/2013
1	Sirolimus (Rapamycin)FDA Link 12/2012
1	Class Ia Phosphatidylinositol 3-KinaseIBA 12/2012
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2012
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 12/2012
1	Carrier Proteins (Binding Protein)IBA 12/2012
1	Phenobarbital (Luminal)FDA Link 11/2012
1	Indicators and Reagents (Reagents)IBA 11/2012
1	Mutant Proteins (Protein, Mutant)IBA 10/2011
1	Microphthalmia-Associated Transcription FactorIBA 10/2011
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 06/2011
1	AnthracyclinesIBA 06/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2011
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2009
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2009
1	Cell Cycle ProteinsIBA 07/2008
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 07/2008
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2008
1	CREB-Binding ProteinIBA 08/2007
1	EndonucleasesIBA 10/2006
1	polyglutamineIBA 11/2005
1	Steroid Receptors (Steroid Receptor)IBA 11/2005
1	ProdrugsIBA 12/2004
1	Carboxylesterase (Hydrolase S)IBA 12/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2004

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2012
1	Adjuvant Chemotherapy 06/2011
1	Ligation 07/2008